Presentation Information
[2P-723]The feasibility of genome editing-mediated gene-silencing therapy for DRPLA
○Taisuke Kato1, Sho Kitahara2, Yuka Mitsuhashi2, Kobayashi Kenta3, Onodera Osamu2 (1. Department of Molecular Neuroscience, Brain Research Institute, Niigata University, 2. Department of Neurology, Brain Research Institute, Niigata University, 3. Department of Viral Vector Development, National Institute for Physiological Science)
Password required to view
Please enter the password printed on your name card.
Online registrants can download your name card from the account page once payment has been successfully processed.
Online registrants can download your name card from the account page once payment has been successfully processed.
Comment
To browse or post comments, you must log in.Log in